Arginase II
US6316199A · kind A · utility
13Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2000 |
| Grant date | Nov 13, 2001 |
| Priority date | — |
| Expiry date | Apr 3, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to Arginase II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.